Such IR783‐stabilized nanodrugs can not only lead to cancer cell apoptosis through HDAC inhibition‐enhanced oxidation therapy but also cooperatively induce immunogenic cell death and promote pro‐inflammatory cytokine gene expression to reshape immunosuppressive microenvironment. The gene discussed is HDAC9; the disease is cancer.